B+
Bull case
20%
Probability
Target price
$28.71
+283.8% vs current
Coverage clusters in the mid-tohigh $20s create an upside narrative if execution holds; near-term sentiment is mixed due to audit/execution risk and target dispersion.
No evidence quality warning is currently attached to this memo.
Coordinated target revisions from major brokers could drive a sustained repricing to the mid/high$20s.
Quarterly results or guidance changes likely to move the stock given dispersion in sellside expectations.
Sustained procedure adoption and reimbursement improvements would support material upside and multiple expansion.
No formal recommendation provided.